m.nwosu
TL2 · Valencia
Contributes reviews on supplier material. Based in Valencia.
Joined 29 September 2024 · last posted 1d · groups: translators
75 posts, newest first. Showing up to 150.
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #46 · Research Methods › N-of-1 designs · 27 Jul 2026 · 1 like I had written a reply contradicting post #42 and deleted it. Here is what survived. My experience of Washout contradicts the reply above. I am posting it as a data…
-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #11 · Sourcing › Red flags · 25 Jul 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. I think the Distinguishing a red flag question is answerable and has not been answered, which is a more…
-
An 18-month record including the parts that went badly Replied, post #79 · Outcomes › Progress reports · 24 Jul 2026 · 0 likes Post #78 answers the question as asked. The question underneath it is different. Reframing 18-month record slightly, because I think the disagreement is about the…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #8 · Compounds › Retatrutide · 21 Jul 2026 · 11 likes Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A phase 2 trial without a dual-agonist comparator arm…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #48 · Practice › Side effects · 13 Jul 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #30 · Compounds › Semaglutide · 12 Jul 2026 · 11 likes Semaglutide formulation has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #14 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 8 likes If you are new and reading this thread for the answer to Detection wavelength: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #36 · Research Methods › Statistics · 3 Jul 2026 · 0 likes I keep a log for Absence of evidence specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #32 · Evidence › Trials · 1 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Deamidation and the close-eluting pair it produces — the long version Replied, post #2 · Analytics › Impurities & related substances · 25 Jun 2026 · 6 likes The opening post and I disagree about the size of the effect, not about the direction. Racemisation produces a diastereomer that is mass-identical and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #101 · Outcomes › Body composition · 24 Jun 2026 · 5 likes Muscle gained during a deficit is possible in specific circumstances and is not the usual case, and the published evidence is clear about which circumstances. If it…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #31 · Documentation › Doc review · 21 Jun 2026 · 9 likes Genuine question rather than a rhetorical one: has anyone here actually observed draft on reconstitution arithmetic, as opposed to read about it? The thread is long and…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #24 · Sourcing › Independent verification · 17 Jun 2026 · 2 likes A supplier's own certificate is not independent. It can be posted, it is useful, and it is labelled for what it is. This is the sort of thing the wiki should carry and…
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #11 · Analytics › HPLC & UHPLC · 17 Jun 2026 · 10 likes 99.2% and 97.8% is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Prescription portability between countries Replied, post #59 · Access › International · 9 Jun 2026 · 13 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change. I…
-
Request: a per-category review queue Replied, post #24 · Meta › Feature requests · 7 Jun 2026 · 3 likes Post #21 is right about the mechanism and I think understates the practical bit. Request with the use case rather than the feature. I frequently want every topic that…
-
The anatomy of a question that gets answered within an hour Replied, post #63 · Start Here › How to Ask · 1 Jun 2026 · 1 like Everything in post #59 holds. The case it does not cover is the one I have. Five questions in one post gets you one answer: the easiest one, usually not the one you…
-
The best-written scientific paper you have read Replied, post #68 · Lounge › Off topic · 27 May 2026 · 31 likes Something worth flagging about best-written scientific paper: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #32 · Analytics › Method validation · 25 May 2026 · 3 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #47 · Analytics › HPLC & UHPLC · 23 May 2026 · 2 likes Post #46 is right about the mechanism and I think understates the practical bit. The honest answer on Area percent versus weight percent is that it depends, and the…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #44 · Practice › Dosing & titration · 21 May 2026 · 0 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #68 · Clinical › Bloodwork · 15 May 2026 · 28 likes Sensible. I would want the same detail before I acted on it either.
-
Tracking intake honestly when appetite is absent Replied, post #20 · Nutrition & Training › Protein & intake · 9 May 2026 · 0 likes Distribution across the day appears to matter less than total for most outcomes, and it matters practically because a single large meal is harder when appetite is…
-
Request: show the solution author in the topic list — what changed since Replied, post #82 · Meta › Feature requests · 4 May 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
Fasting versus non-fasting and which tests care Replied, post #18 · Clinical › Bloodwork · 26 Apr 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That is a description of practice, not a…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #6 · Compounds › Semaglutide · 18 Apr 2026 · 14 likes Worth separating two things that post #2 runs together. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #39 · Start Here › Welcome · 11 Apr 2026 · 0 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
Second pass at: Identical chromatograms across two different lots Replied, post #85 · Sourcing › Red flags · 22 Mar 2026 · 4 likes That is a fair summary of where the discussion has got to.
-
Which fields on a certificate actually matter, ranked Replied, post #25 · Analytics › COA interpretation · 18 Mar 2026 · 0 likes Adding the measurement that post #22 says would settle it. The distinction between release testing and characterisation is one industrial documents make and retail ones…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #10 · Evidence › Trials · 15 Mar 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
A plateau that disappeared when I changed how I measured Replied, post #18 · Outcomes › Progress reports · 23 Feb 2026 · 0 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. A note on scope: what I am saying about plateau applies to the…
-
About the Calculators category Replied, post #3 · Data & Tools › Calculators · 16 Jan 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Research-use-only labelling: what it means and what it does not Replied, post #86 · Sourcing › Regulatory · 12 Jan 2026 · 3 likes Coming back to post #82, because the follow-up matters more than the original answer. The documentation on research-use-only labelling is better than this thread and I…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #17 · Compounds › Tirzepatide · 7 Jan 2026 · 1 like Worth separating two things that post #13 runs together. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #38 · Regional › UK & Ireland · 4 Jan 2026 · 11 likes Private prescribing arrangements differ in what they include, and the differences are more consequential than the headline price. The part I am sure of is shorter than…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #48 · Access › Pricing · 29 Dec 2025 · 17 likes The arithmetic in post #46 is right; the assumption feeding it is the part to check. A cheaper option that arrives slowly has a cost in the form of running out, and…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #4 · Compounds › Secretagogues & GH axis · 20 Dec 2025 · 4 likes The opening post put the caveat in the right place and I want to underline it. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Request: a diff view for wiki revisions — the long version Replied, post #83 · Meta › Feature requests · 12 Dec 2025 · 9 likes Reporting rather than recommending, on diff view for wiki revisions. What happened is above. Whether it should have is a different question and not one I am qualified…
-
Robustness: the parameters worth deliberately varying Replied, post #34 · Analytics › Method validation · 1 Dec 2025 · 3 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #55 · Compounds › Other compounds · 24 Nov 2025 · 4 likes Post #52 describes the usual case. This is about the unusual one. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
-
How to ask about something you suspect is a bad idea Replied, post #22 · Start Here › How to Ask · 5 Nov 2025 · 13 likes Confirming post #19 from a second method, which matters more than confirming it from a second person. A photograph of a vial is rarely useful and a photograph of a…
-
Angle of injection and whether 90 degrees is always right Replied, post #45 · Practice › Administration · 4 Nov 2025 · 10 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #20 · Analytics › Home & field testing · 28 Sep 2025 · 18 likes Picking up post #19: that is the part I would want checked first. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #2 · Start Here › Welcome · 14 Sep 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Titles that describe the question, not the situation Replied, post #90 · Start Here › How to Ask · 7 Sep 2025 · 1 like Picking up post #89: that is the part I would want checked first. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #36 · Compounds › Other compounds · 5 Sep 2025 · 2 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
[2026 update] Comparing documentation quality across the directory, tabulated Replied, post #3 · marked as the solution · Sourcing › Vendor reports · 13 Aug 2025 · 25 likes Adding the measurement that post #2 says would settle it. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and…
-
Trial registration and comparing the protocol with the paper Replied, post #26 · Evidence › Trials · 1 Aug 2025 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
What a documentation review can and cannot tell you Replied, post #49 · Sourcing › Independent verification · 26 Jul 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #135 · Access › Insurance & coverage · 16 Jun 2025 · 4 likes Post #134 answers the question as asked. The question underneath it is different. Documentation your clinician can provide: letters from clinicians describing why…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #25 · Data & Tools › Calculators · 14 Jun 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Tracking that stops updating and then resumes Replied, post #3 · Sourcing › Logistics · 11 Jun 2025 · 26 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
A well-designed study with a badly written abstract Replied, post #126 · Evidence › Study critique · 3 Jun 2025 · 13 likes Reading back through the well-designed study threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #124 · Sourcing › Independent verification · 20 May 2025 · 2 likes I had written a reply contradicting post #120 and deleted it. Here is what survived. A record with four results over sixteen months is a thin record rather than a bad…
-
Follow-up: Documentation that appears only after payment Replied, post #80 · Sourcing › Red flags · 15 May 2025 · 0 likes Two things can be true about Documentation at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Documenting an adverse event properly — the long version Replied, post #3 · Safety › Adverse events · 10 May 2025 · 0 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real. I have written…
-
Adjudicated events and why the definition matters — the long version Replied, post #140 · Evidence › Trials · 7 May 2025 · 27 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Scheduled maintenance and what will be unavailable Replied, post #124 · Meta › Announcements · 26 Apr 2025 · 10 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #45 · Practice › Reconstitution · 17 Mar 2025 · 28 likes Worth separating two things that post #43 runs together. A request rather than an answer: could whoever has the primary source for reconstituting a multi-strength kit…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #55 · Pharmacology › Receptor biology · 7 Mar 2025 · 0 likes Distinguishing three things in the biased agonism discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
-
The topic list is dense — is that deliberate? Replied, post #89 · Meta › Site feedback · 27 Jan 2025 · 20 likes The arithmetic in post #88 is right; the assumption feeding it is the part to check. Moderation decisions: if you disagree with a moderation decision, raising it here…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #48 · Compounds › Secretagogues & GH axis · 24 Jan 2025 · 10 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Follow-up: Individual participant data versus aggregate data Replied, post #98 · Evidence › Meta-analyses · 11 Jan 2025 · 17 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search.
-
A supplier that answers analytical questions with restated claims Replied, post #7 · Sourcing › Red flags · 6 Jan 2025 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed supplier, as opposed to read about it? The thread is long and I cannot tell.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #57 · Compounds › Semaglutide · 29 Dec 2024 · 32 likes On post #53 — agreed on the reasoning, with one qualification. Speaking only to Semaglutide formulation as I have actually seen it, rather than as it is usually…
-
Promotion criteria, and the one that stops most nominations Replied, post #125 · Documentation › Doc review · 28 Nov 2024 · 0 likes Picking up post #124: that is the part I would want checked first. My understanding of promotion criteria is a few years old and may have been superseded. If it has…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #63 · Practice › Administration · 28 Sep 2024 · 0 likes I had written a reply contradicting post #61 and deleted it. Here is what survived. The version of site rotation scheme that I was taught turned out to be a teaching…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #16 · Nutrition & Training › Protein & intake · 18 Sep 2024 · 3 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Progressive overload when the scale is falling — one year on Replied, post #50 · Nutrition & Training › Resistance training · 12 Sep 2024 · 28 likes Progressive overload is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Reporting a discrepancy without making an allegation Replied, post #30 · Sourcing › Vendor reports · 17 Aug 2024 · 1 like Post #27 put the caveat in the right place and I want to underline it. Reading back through the reporting a discrepancy threads from last year, the same three questions…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #78 · Evidence › Journal club · 29 Jul 2024 · 21 likes The question underneath LEADER is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect to…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #8 · Sourcing › Red flags · 23 Jul 2024 · 8 likes The failure mode on Pricing far outside the range is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too…
-
Cold packs, phase-change material, and what survives ten days Replied, post #27 · Sourcing › Logistics · 19 Jun 2024 · 19 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
The mass-error checker and its intended scope Replied, post #43 · Data & Tools › Calculators · 11 Jun 2024 · 5 likes I had read the opposite somewhere and cannot now find where, which tells me something.